Insider · CIK 0001672718
O'Neill Vincent
Reports to the SEC for 2 companies · NEW HAVEN, CT
Transactions
50
Companies
2
Filings
8
CIK
0001672718
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2024-12-16 | BTAIBioXcel Therapeutics, Inc.S Sale | −$58.13 |
| 2024-12-14 | BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion | — |
| 2024-12-14 | BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion | — |
| 2024-10-03 | BTAIBioXcel Therapeutics, Inc.S Sale | −$3,055.8 |
| 2024-09-17 | BTAIBioXcel Therapeutics, Inc.A Award | — |
| 2024-09-16 | BTAIBioXcel Therapeutics, Inc.S Sale | −$95.33 |
| 2024-09-14 | BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion | — |
| 2024-09-14 | BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion | — |
| 2024-07-22 | BTAIBioXcel Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2024-06-17 | BTAIBioXcel Therapeutics, Inc.S Sale | −$199.175 |
| 2024-06-14 | BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion | — |
| 2024-06-14 | BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion | — |
| 2024-04-04 | BTAIBioXcel Therapeutics, Inc.S Sale | −$432.482 |
| 2024-03-15 | BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion | — |
| 2024-03-15 | BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion | — |
| 2024-03-14 | BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion | — |
| 2024-03-14 | BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion | — |
| 2023-12-14 | BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion | — |
| 2023-12-14 | BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion | — |
| 2023-09-14 | BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion | — |
| 2023-09-14 | BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion | — |
| 2023-06-14 | BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion | — |
| 2023-06-14 | BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion | — |
| 2023-03-15 | BTAIBioXcel Therapeutics, Inc.S Sale | −$16.6K |
| 2023-03-15 | BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsA Award | — |
| 2023-03-15 | BTAIBioXcel Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-03-14 | BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion | — |
| 2023-03-14 | BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion | — |
| 2023-01-20 | BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion | +$12.2K |
| 2023-01-20 | BTAIBioXcel Therapeutics, Inc.S Sale | −$891K |
| 2023-01-20 | BTAIBioXcel Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion | — |
| 2022-03-14 | BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsA Award | — |
| 2021-03-25 | BTAIBioXcel Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2021-02-17 | BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion | +$6,150 |
| 2021-02-17 | BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion | +$110K |
| 2021-02-17 | BTAIBioXcel Therapeutics, Inc.S Sale | −$124K |
| 2021-02-17 | BTAIBioXcel Therapeutics, Inc.S Sale | −$308K |
| 2021-02-17 | BTAIBioXcel Therapeutics, Inc.S Sale | −$382K |
| 2021-02-17 | BTAIBioXcel Therapeutics, Inc.S Sale | −$542K |
| 2021-02-17 | BTAIBioXcel Therapeutics, Inc.S Sale | −$34.3K |
| 2021-02-17 | BTAIBioXcel Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion | — |
| 2021-02-17 | BTAIBioXcel Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion | — |
| 2021-01-19 | BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion | +$10.3K |
| 2021-01-19 | BTAIBioXcel Therapeutics, Inc.S Sale | −$327K |
| 2021-01-19 | BTAIBioXcel Therapeutics, Inc.S Sale | −$624K |
| 2021-01-19 | BTAIBioXcel Therapeutics, Inc.S Sale | −$136K |
| 2021-01-19 | BTAIBioXcel Therapeutics, Inc.S Sale | −$77.2K |
| 2021-01-19 | BTAIBioXcel Therapeutics, Inc.S Sale | −$72.2K |
| 2021-01-19 | BTAIBioXcel Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion | — |
| 2020-12-28 | BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion | +$10.3K |
Recent filings
- 4O'Neill Vincent0001104659-25-030688SEC(opens sec.gov)
- 4O'Neill Vincent0001104659-24-129464SEC(opens sec.gov)
- 4O'Neill Vincent0001104659-24-106060SEC(opens sec.gov)
- 4O'Neill Vincent0001104659-24-100747SEC(opens sec.gov)
- 4O'Neill Vincent0001104659-24-073000SEC(opens sec.gov)
- 4O'Neill Vincent0001104659-24-044862SEC(opens sec.gov)
- 4O'Neill Vincent0001104659-23-126916SEC(opens sec.gov)
- 4O'Neill Vincent0001104659-23-101637SEC(opens sec.gov)
Companies
Address
C/O BIOXCEL THERAPEUTICS, INC. 555 LONG WHARF DRIVE, 12TH FLOOR
NEW HAVEN, CT, 06511